Al Hammadi Company for Development and Investment (4007.SE)

Also known as:  Al Hammadi
Data delayed by 15 minutes
34.80 SAR 0.351.02%
As of 09 MAY 2021 10:43 GMT|Saudi SE

Al Hammadi Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
28.8
Upside
-
Target Price (Mean)
-
52Wk
26.7 04 FEB
36.0 03 MAY

Open
35.00 SAR
Previous Close
34.45 SAR
Turnover
11.98M SAR
EPS
1.09 SAR
Volume
346,863
Transactions
365
Market Cap
4.13B SAR
IPO Date
14-Jul-2014
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Al Hammadi Company for Development and InvestmentLast updated on: 31 March 2020

Business Summary
Ownership, operation and management of general hospitals; distribution of medical equipment, medical supplies and pharmaceuticals.
Country of Incorporation
Ownership Type
Established In
1985
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4007.SSEOrdinarySARSaudi SE4007

Contact details

Primary address
Building: Al Hammadi Hospital - Al Olaya Building
Street: Al Oruba Street
Area: Al Olaya District
P.O. Box: 55004
Country: Saudi Arabia
City: Riyadh
City Suffix: 11534
CONTACT
Region
Riyadh
More
All Press Releases

talabat launches #IftarforIndia today, in support of India

Continuing the theme of giving back this Ramadan, talabat has pledged that for every food order placed between 5pm - 8pm on Sunday 9 May, the organisation will donate the value of a meal to the World Food Programme to help communities affected by the COVID-19 pandemic in India

Press Release - Sunday 9 May 2021
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

HE Mohammed Ibrahim Taher Al Hamadi
Chief Executive Officer and Managing Director
Mr Mohammed Said Suleiman Al Saafeen
Chief Financial Officer
Dr Abdulaziz Saleh Mohammed Hamad Al Hammadi
Chief Operating Officer

Board Members

Mr Saleh Mohammed Hamad Al Hammadi
Chairman
Dr Abdulaziz Mohammed Hamad Al Hammadi
Vice Chairman
Dr Sami Abdullah Dakheilallah Al Said
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
MOUWASAT MED SEV182.800 SAR0.11
PHARMACEUTICALS43.400 SAR0.93
SAUDI GERMAN HSP38.150 SAR-0.78
SULAIMAN ALHABIB149.800 SAR-0.13
DALLAH HEALTH64.300 SAR0.31
More
More

Most Viewed Stocks

Stock Screener

More